ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.049093561024907 0.66165423
NSC 33570 Null 0.049093561024907 0.1522243
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.049093561024907 0.5026349
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.049093561024907 0.061157851
NSC 359239 Antibiotic X-14766A 0.049093561024907 0.051293533
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.049093561024907 0.45180269
NSC 42972 Null 0.049093561024907 0.20778006
NSC 45236 Null 0.049093561024907 0.36294546
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.049093561024907 0.36138738
NSC 603071 Aminocamptothecin 0.049093561024907 0.67161091
Total:122  Current:116    [First] [Prev] [Next] [Last]